Technology | Lung Imaging | October 05, 2018

Platform creates augmented reality to see fluoroscopically invisible lung lesions

Body Vision Medical Announces Release of LungVision

October 5, 2018 — Body Vision Medical, a medical device company specializing in lung cancer diagnostics, announced the launch of its LungVision platform. The platform will be presented at the CHEST conference, Oct. 7-10 in San Antonio, Texas.

"Body Vision provides a great tool that has changed the way we approached peripheral nodules. Its unique technology creates augmented reality with the ability to see fluoroscopically invisible lesions and the pathways under the live fluoro, while tracking a patient breathing," said D. Kyle Hogarth, M.D., FCCP, president of the Society for Advanced Bronchoscopy, associate professor of medicine, director of bronchoscopy at the University of Chicago. "Once the technology has guided us to the lesion, we confirm the lesion's relationship to the airway with radial-EBUS [endobronchial ultrasound]. We then use our off-the-shelf biopsy instruments via the LungVision catheter. The augmented fluoro image, integrated with the radial EBUS images, allows us to obtain tissue samples with continuous real-time confirmation of location. The beauty of it all is how simple and elegant the technology is."

Body Vision CEO Dorian Averbuch said the product targets small pulmonary nodules that, if diagnosed early, can be resected to cure lung cancer. The technology provides step-by-step guidance through planning, navigation and lesion localization during biopsy.

The clinical experience with the LungVision platform will be featured through the following panel presentations during the CHEST conference at San Antonio, TX:

  • Sun. Oct. 7
    • Krish Bhadra, M.D., Novel Augmented Fluoroscopic Imaging Platform Accuracy Assessment during Navigation Bronchoscopy in Simultaneous Comparison with Cone Beam CT and Radial EBUS
    • D. Kyle Hogarth, M.D., FCCP, A Novel Endobrachial Fluoroscopic Navigation and Localization System: a summary of a multi-center LungVision Trial
  • Tue., Oct. 9
    • Patrick E. Whitten, M.D., FCCP, Augmented Endobronchial Fluoroscopic Navigation and Localization System: Integration of Multimodalities and Biopsy Tools to Increase Diagnostic Yield

For more information: www.bodyvisionmedical.com


Related Content

News | Artificial Intelligence

Sept. 13, 2024 — Bayer Calantic Digital Solutions has announced the availability of a new eBook that addresses how ...

Time September 12, 2024
arrow
News | Virtual and Augmented Reality

While the use of augmented reality (AR) in healthcare is still in its early stages, the potential for expansion is ...

Time August 08, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 22, 2024 — Healthcare artificial intelligence (AI) systems provider, Qure.ai, has announced its receipt of a Class ...

Time July 22, 2024
arrow
News | Radiation Therapy

July 3, 2024 — Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support ...

Time July 03, 2024
arrow
News | Artificial Intelligence

June 27, 2024 — Thirona, a Netherlands-based global company providing high-precision advanced lung image analysis with ...

Time June 27, 2024
arrow
News | Neuro Imaging

June 12, 2024 — Brainet, a developer of cutting-edge diagnostic tools for assessing brain health, and SimonMed Imaging ...

Time June 12, 2024
arrow
News | Artificial Intelligence

June 11, 2024 — A new study led by researchers at Emory AI.Health, published in the Journal of Computers in Medicine and ...

Time June 11, 2024
arrow
News | Clinical Trials

May 30, 2024 — Researchers from Penn Medicine’s Abramson Cancer Center (ACC) and the Perelman School of Medicine at the ...

Time May 29, 2024
arrow
Subscribe Now